RESUMEN
The aim of the study presented here was to evaluate the in vitro activity of faropenem, a new member of the penem class intended for oral administration, compared with 11 other antimicrobial agents against a large number of Streptococcus pneumoniae strains isolated from adults and children with bloodstream infections in France. The minimum inhibitory concentration of faropenem against 90% of the pediatric strains tested was generally one to two dilutions lower than the most potent beta-lactam agents (i.e., 0.5 micro g/ml for faropenem vs. 1 for amoxicillin, 1 for cefotaxime and 0.5 micro g/ml for ceftriaxone). Against the adult strains, only moxifloxacin had a MIC(90) value similar to faropenem (i.e., 0.25 micro g/ml for both agents). Faropenem seems to be a promising antimicrobial agent for the treatment of adult and pediatric Streptococcus pneumoniae infections.
Asunto(s)
Farmacorresistencia Microbiana , Lactamas/farmacología , Streptococcus pneumoniae/efectos de los fármacos , Antibacterianos/farmacología , Bacteriemia/tratamiento farmacológico , Bacteriemia/microbiología , Niño , Preescolar , Francia , Humanos , Lactante , Pruebas de Sensibilidad Microbiana , Infecciones Neumocócicas/diagnóstico , Infecciones Neumocócicas/tratamiento farmacológico , Muestreo , Sensibilidad y Especificidad , Streptococcus pneumoniae/aislamiento & purificación , beta-LactamasRESUMEN
All bloodstream strains, total 1463, isolated during a 1 month period in 105 hospitals representing all geographical areas in France were collected to study their antimicrobial susceptibility. The three major species were Escherichia coli, Staphylococcus aureus and coagulase-negative staphylococci. Among the 242 S. aureus, 87 were resistant to methicillin and among those 99% were resistant to ciprofloxacin, 11.5% to gentamicin, 1% to quinupristin/dalfopristin and 8% were heterogeneously resistant to vancomycin. Study of the methicillin-resistant S. aureus indicated that 12 clones had disseminated in French hospitals, six being heterogeneously resistant to vancomycin. Among the Streptococcus pneumoniae, 43% showed decreased susceptibility to the penicillins and 42% to erythromycin. One isolate was highly resistant to fluoroquinolones. Gentamicin, cefotaxime, ciprofloxacin and gatifloxacin resistance was rare in Enterobacteriaceae with 95% of strains susceptible. The incidence of extended-spectrum beta-lactamases was quite low. Moreover more than 25% of Pseudomonas aeruginosa strains were resistant to ciprofloxacin and gentamicin. The magnitude of antibiotic resistance in bloodstream isolates, in particular Gram-positive bacteria, emphasizes the importance of hospital control measures, rational prescribing policies and new vaccine strategies.
Asunto(s)
Bacteriemia/epidemiología , Bacteriemia/microbiología , Bacterias/efectos de los fármacos , Antiinfecciosos/farmacología , Bacterias/genética , Enterobacteriaceae/efectos de los fármacos , Escherichia coli/efectos de los fármacos , Francia/epidemiología , Genes Bacterianos , Humanos , Pruebas de Sensibilidad Microbiana , Estudios Prospectivos , Quinolonas/farmacología , Staphylococcus aureus/efectos de los fármacos , Streptococcus/efectos de los fármacosRESUMEN
Macrophage activation plays a central role in host defense against a variety of pathogens via inducible messengers. The transcription factor NF-kappaB controls the synthesis of cytokines involved in immune responses. In quiescent cells, NF-kappaB is located in the cytosol bound to an inhibitor IkappaB. Upon appropriate signal, NF-KB translocates to the nucleus and binds to DNA. The present study investigated the involvement of an immunomodulator, (diHDA-glycerol) on the NF-kappaB/IkappaB complex. Results were compared to those obtained with lipopolysaccharide (LPS) as a major virulence factor in bacterial sepsis. Data showed that exposure of J774.1 cells either to LPS or diHDA-glycerol substantially increased with time the nuclear levels of NF-kappaB complexes. Antibodies to various NF-kappaB proteins supershifted p50, p65 and to a lesser extent c-rel. Western blot analyses showed a rapid cytosolic IkappaB-alpha turn over following LPS exposure in contrast to diHDA-glycerol treatment. Further experiments investigated the involvement of protein kinase C (PKC) by using two inhibitors, staurosporine and H7. Pretreatment of J774.1 with either inhibitor prior to diHDA-glycerol or LPS exposure decreased NF-kappaB activation. Our results indicate that diHDA-glycerol was acting on NF-kappaB through IkappaB regulative mechanisms differing from those used by LPS. DiHDA-glycerol is likely acting on many other transcription factors targeting distinct genes implied in up regulation of the immune system.
Asunto(s)
Adyuvantes Inmunológicos/farmacología , Éteres de Glicerilo/farmacología , Proteínas I-kappa B , FN-kappa B/metabolismo , Animales , Secuencia de Bases , Línea Celular , Proteínas de Unión al ADN/metabolismo , Lipopolisacáridos/farmacología , Activación de Macrófagos/efectos de los fármacos , Macrófagos/efectos de los fármacos , Macrófagos/inmunología , Macrófagos/metabolismo , Ratones , Inhibidor NF-kappaB alfa , Sondas de Oligonucleótidos/genética , Sondas de Oligonucleótidos/metabolismo , Proteína Quinasa C/metabolismoAsunto(s)
Adenoma/diagnóstico , Quistes Aracnoideos/diagnóstico , Encéfalo/patología , Malformaciones Arteriovenosas Intracraneales/diagnóstico , Imagen por Resonancia Magnética , Neoplasias Hipofisarias/diagnóstico , Esclerosis Tuberosa/diagnóstico , Adenoma/complicaciones , Adulto , Quistes Aracnoideos/complicaciones , Femenino , Humanos , Malformaciones Arteriovenosas Intracraneales/complicaciones , Neoplasias Hipofisarias/complicaciones , Esclerosis Tuberosa/complicacionesRESUMEN
PURPOSE OF THE STUDY: To determine the contribution of magnetic resonance (MR) imaging in the diagnosis of meniscal ossicle. MATERIALS AND METHODS: Two cases of meniscal ossicle were evaluated by plain radiography and MR imaging. Sagittal and coronal T1-weighted (400/15), proton density and T2-weighted (2,000/20,80) sequences were performed with 0.5 T magnet. RESULTS: Plain radiography revealed a triangular ossified body in the postero-medial aspect of the knee joint. MR images demonstrated that these ossicles were located within the posterior horn of the medial meniscus. The signal of these ossicles was isointense with that of bone marrow in all sequences. CONCLUSION: MR findings allow the diagnosis of meniscal ossicle and help to differentiate it from osteochondral loose body.
Asunto(s)
Imagen por Resonancia Magnética , Meniscos Tibiales , Osificación Heterotópica/diagnóstico , Adulto , Humanos , Masculino , Meniscos Tibiales/diagnóstico por imagen , Persona de Mediana Edad , Osificación Heterotópica/diagnóstico por imagen , Osificación Heterotópica/etiología , RadiografíaRESUMEN
The immunomodulating properties of arglabin, a sesquiterpene lactone isolated from Artemisia myriantha Wall. (Asteraceae) were investigated using the murine macrophage tumor line J774.1. Arglabin-stimulated macrophages displayed a strong cytotoxic activity and the lowest doses (1.25 micrograms/mL and 0.125 micrograms/mL) induced a significant stimulation of cell mitochondrial metabolism, which correlated with [3H]TdR uptake by J774.1 cells under the same experimental conditions. In addition, the secretion of cytokines involved in host defence mechanisms--IL-1, TNF-alpha, and IL-2--was investigated upon incubation of J774-1 cells with arglabin. Arglabin triggered the production of the three cytokines from J774-1 cells. However, the pattern of cytokine secretion differed to some extent, according to the methodology used for cytokine measurement: either traditional bioassay or specific immunoassay (ELISA). Our data emphasize a possible proliferative effect of arglabin in the traditional bioassays, at least for the highest concentrations used. The results were verified with specific ELISA immunoassays. Using either method, lower concentrations of arglabin (ranging from 12.5 micrograms/mL to 0.125 micrograms/mL) were the most effective in inducing IL-1, TNF-alpha, or IL-2 secretion. In addition, preliminary data on phagocytosis showed that arglabin enhanced the uptake of fluorescent latex beads by J774.1 cells.
Asunto(s)
Citocinas/metabolismo , Medicamentos Herbarios Chinos/farmacología , Macrófagos/efectos de los fármacos , Sesquiterpenos/farmacología , Animales , Línea Celular , ADN/biosíntesis , Interleucina-1/metabolismo , Interleucina-2/metabolismo , Macrófagos/inmunología , Macrófagos/metabolismo , Ratones , Mitocondrias/metabolismo , Fagocitosis/efectos de los fármacos , Sesquiterpenos/inmunología , Sesquiterpenos de Guayano , Factor de Necrosis Tumoral alfa/metabolismoRESUMEN
The effects of Taxol on some immunological parameters were investigated, in vitro, in the murine macrophage cell line J774.1. Mitochondrial dehydrogenase activity and (3H) TdR incorporation were shown to be increased in Taxol treated cells. Likewise, Taxol induced TNF alpha secretion. But Taxol seemed to be a weak inducer of the two interleukins IL-1 and IL-2, since their detection occurred late in the cell culture supernatants.
Asunto(s)
Alcaloides/farmacología , Antineoplásicos Fitogénicos/farmacología , Macrófagos/efectos de los fármacos , Animales , Línea Celular , ADN/biosíntesis , Interleucina-1/biosíntesis , Interleucina-2/biosíntesis , Macrófagos/inmunología , Macrófagos/metabolismo , Ratones , Paclitaxel , Fagocitosis/efectos de los fármacos , Factor de Necrosis Tumoral alfa/biosíntesisRESUMEN
The anti-tumoral activity of taxol encapsulated either in liposomes or in nanocapsules was compared with that of free taxol, using the P388 and L1210 leukaemia test systems. The in vitro inhibition of cell growth was measured after 48 h and 96 h exposure to various concentrations of taxol. With P388 cells, the inhibitory activities of the three forms of the drug were similar. With the L1210 cells, however, the concentrations required for a 50 per cent inhibition of cell growth (IC50) after 48 h exposure to the drug were greater for nanocapsules than for liposomes or free taxol, the values being 0.060, 0.043 and 0.035 micrograms ml-1, respectively. However, a greater efficiency of nanocapsules was observed after 96 h exposure. Using cytomorphometric analysis, no difference was found between L1210 cells treated either with free or encapsulated taxol. In vivo, mice bearing P388 leukaemia, and treated either with taxol solubilized with 5 per cent DMSO + 5 per cent cremophor in saline solution, or with taxol encapsulated in liposomes (IP daily dose of 12.5 mg Kg-1 body weight x 4 days) showed ILS values of 65.8% and 67.9% respectively. Nanocapsules proved to be toxic, apparently due to their composition: this problem is currently under investigation.
Asunto(s)
Alcaloides/administración & dosificación , Antineoplásicos Fitogénicos/administración & dosificación , Leucemia L1210/tratamiento farmacológico , Leucemia P388/tratamiento farmacológico , Leucemia Experimental/tratamiento farmacológico , Alcaloides/uso terapéutico , Animales , Antineoplásicos Fitogénicos/uso terapéutico , Cápsulas , Composición de Medicamentos , Femenino , Leucemia L1210/mortalidad , Leucemia P388/mortalidad , Liposomas , Ratones , Paclitaxel , Células Tumorales Cultivadas/efectos de los fármacosRESUMEN
In order to compare the antineoplastic activities of taxol A, taxol B, a mixture of the two (taxol A 72%) and vinblastine, a human ovarian tumor serially transplanted into 104 female athymic mice was used. In the first experiment (11th passage), the antineoplastic activities of taxol A, taxol B and the mixture taxol AB were tested. The same dose was used in each case (12.5 mg/kg i.e. 1/20 of the evaluated LD50 value). It was administered subcutaneously for 5 consecutive days. Three courses of treatment were performed, with 2 rest periods of 1 week in between. All the taxol derivatives produced a statistically significant delay in the tumor growth. However, taxol B had the lowest chemotherapeutic response. In the second experiment (18th passage), different dose levels were administered (mixture 12.5 mg/kg/day x 4 - taxol A 8.8. mg/kg/day x 4 - taxol B 3.5 mg/kg/day x 4 - vinblastine 0.5 mg/kg/day x 2). For all the taxol derivatives 4 treatment courses with 3 rest periods of 4 days were used, and for vinblastine 4 treatment courses with 3 rest periods of 1 week. At the end of the second experiment, vinblastine, taxol A and a mixture of the two showed similar significant activity, whereas no objective antitumor response was observed following the taxol B treatment at the dose level chosen. The experimental results obtained clearly demonstrate that, in the taxane system, the greatest degree of antineoplastic activity can be attributed to taxol A.
Asunto(s)
Alcaloides/uso terapéutico , Antineoplásicos Fitogénicos/uso terapéutico , Cistadenocarcinoma/tratamiento farmacológico , Neoplasias Ováricas/tratamiento farmacológico , Taxoides , Alcaloides/administración & dosificación , Animales , Antineoplásicos Fitogénicos/administración & dosificación , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Cistadenocarcinoma/patología , Ensayos de Selección de Medicamentos Antitumorales , Femenino , Humanos , Ratones , Ratones Desnudos , Trasplante de Neoplasias , Neoplasias Ováricas/patología , Paclitaxel , Trasplante Heterólogo , Vinblastina/administración & dosificaciónRESUMEN
To test the antineoplastic activity of taxol, a natural product isolated from yew (Taxus baccata L.), six human tumors transplanted into athymic mice were used (primary tumors of breast, endometrium, ovary, brain, lung and a recurrence of tongue tumor). While the growth rates varied with the histopathological characteristics of different tumor types, all mice were treated at a mean tumor volume of 200 +/- 8 mm3. Taxol was given SC at a dose level of 12.5 mg/kg per injection per day for 5 consecutive days out of 7 over a period of 3 weeks. With this schedule antitumor responses were obtained in all of the six neoplasms xenografted into nude mice. In the case of the ductal carcinoma of the breast total tumor regressions were observed in four of the five treated animals. In the five other experimental models taxol produced significant growth delays. We believe that the results of these initial tests on the nude mouse--human tumor xenograft system are convincing and justify clinical assessment of this drug.
Asunto(s)
Alcaloides/uso terapéutico , Antineoplásicos , Neoplasias Experimentales/tratamiento farmacológico , Adulto , Anciano , Alcaloides/toxicidad , Animales , Femenino , Humanos , Masculino , Ratones , Ratones Desnudos , Persona de Mediana Edad , Trasplante de Neoplasias , Paclitaxel , RatasRESUMEN
In order to study the antitumour activity of taxol (a diterpene of the taxane type) isolated from Yew: Taxus baccata L. (Taxacae), human tumours implanted as xenografts in athymic Mice were used. Swiss nude mice were treated subcutaneously (12.5 mg/kg/injection/day for 5 consecutive days out of 7, over a period of 3 weeks). Treatment by taxol of a liver metastasis of a breast tumour, a tongue primary tumour and a skin metastasis of bronchial carcinoma gave statistically significant results (0,01 greater than P greater than 0,001 and P less than 0,001). However, taxol showed a very moderate antitumour activity against a transplanted primary tumour of the colon.